impact factor
logo
 

LER & CER: letter to Editor Rheumatology

 

Baricitinib plus leflunamide: a potentially dangerous combination?


1, 2, 3

 

  1. Department of Rheumatology, University Hospital Kerry, Ireland.
  2. Department of Rheumatology, University Hospital Kerry, Ireland.
  3. Department of Rheumatology, University Hospital Kerry, Ireland. fahd_adeeb@yahoo.com

CER14320
2021 Vol.39, N°1 ,Suppl.128
PI 0031, PF 0032
LER & CER: letter to Editor Rheumatology

Free to view
(click on article PDF icon to read the article)

PMID: 33634779 [PubMed]

Received: 12/12/2020
Accepted : 02/02/2021
In Press: 19/02/2021
Published: 19/02/2021

Rheumatology Article